DAFNA Capital Management LLC

Position in PRCT — PROCEPT BioRobotics Corp

CIK 1389933 LOS ANGELES, CA

Position in PRCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,709,600

-$291,600 QoQ

Shares Held

120,000

0.0% QoQ

Ownership

0.210%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#77

of 250 holders

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $46,082,606 across 11 Medical Devices names. PRCT ranks #7 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXGN	Axogen, Inc.	208,960	$9,651,862
2	PODD	Insulet Corp	61,870	$9,419,707
3	DXCM	Dexcom Inc	86,279	$5,810,890
4	INGN	Inogen Inc	845,179	$5,451,404
5	TNDM	Tandem Diabetes Care Inc	355,208	$5,360,088
6	KIDS	Orthopediatrics Corp	189,130	$3,618,056
7	PRCT	PROCEPT BioRobotics Corp This page	120,000	$2,709,600
8	PROF	Profound Medical Corp.	260,360	$1,731,394

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,709,600	120,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$3,001,200	120,000	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,775,200	120,000	+3900.0%	Shares	Sole	2026-02-17
2025-06-30	$172,800	3,000	-78.6%	Shares	Sole	2025-08-14
2024-06-30	$854,893	13,994	-74.6%	Shares	Sole	2024-08-14
2024-03-31	$2,717,852	54,995	-13.1%	Shares	Sole	2024-05-15
2023-12-31	$2,652,903	63,300	-5.9%	Shares	Sole	2024-02-14
2023-09-30	$2,208,113	67,300	+741.2%	Shares	Sole	2023-11-14
2023-06-30	$282,800	8,000	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.